benzo
b
furo
oxazin
antiosteoclast
bone
resorpt
activ
antagonist
activ
receptor
growth
inhibitori
activ
mia
characterist
exoformylmethylen
group
oxazin
ring
zisom
stabl
eisom
zisom
z
react
phosphon
reagent
two
differ
condit
obtain
variou
butadien
deriv
contain
benzo
b
furo
oxazin
skeleton
typic
compound
evalu
antiosteoclast
bone
resorpt
activ
antagonist
activ
receptor
growth
inhibitori
activ
mia
compound
show
potent
antiosteoclast
bone
resorpt
activ
compar
e
deriv
fuse
aromat
ring
show
variou
bioactiv
antihuman
coronaviru
activ
express
inhibit
activ
inhibit
human
leukocyt
elastas
inhibit
human
cathepsin
g
inhibit
chymotrypsin
inhibit
serin
proteas
complement
system
inhibit
thrombin
inhibit
human
cytomegaloviru
proteas
studi
advanc
sever
oxazin
ring
cycliz
reaction
prepar
oxazin
deriv
past
decad
oxazin
ring
cycliz
examin
aromat
carbonylamin
carbonyl
function
group
ortho
posit
repres
exampl
one
shown
scheme
thu
aromat
carbonylamin
carboxyl
acid
ester
amid
alcohol
group
oposit
subject
cycliz
adjac
group
pair
form
aromat
ring
fuse
oxazin
lack
examin
oxazin
cycliz
aromat
carbonylamin
keton
group
oposit
report
novel
oxazin
cycliz
reaction
b
furan
repres
vilsmeierhaackarnold
reaction
condit
prepar
novel
z
b
furo
oxazin
deriv
recent
substanti
effort
made
toward
discoveri
select
estrogen
receptor
modul
serm
sever
current
market
tamoxifen
treatment
breast
cancer
raloxifen
prevent
treatment
osteoporosi
b
advanc
clinic
trial
lasofoxifen
bazedoxifen
serm
character
least
two
common
structur
featur
phenol
hydroxyl
group
phenoxyethylamino
group
phenyloch
ch
n
b
phenoxyethylamino
group
postul
import
bind
central
core
estrogen
receptor
also
suggest
influenc
endometri
properti
serm
women
antiestrogen
side
chain
b
recent
report
compound
prepar
current
studi
display
potent
antibon
resorpt
activ
vitro
exhibit
potent
antiosteopen
effect
vivo
compound
show
equival
activ
vitro
vivo
assay
estrogen
raloxifen
current
examin
serm
activ
possibl
develop
new
medicin
treat
osteoporosi
compound
e
e
b
furo
acetaldehyd
possess
phenoxyethenylamino
moieti
furan
oxygen
atom
nitrogen
atom
suggest
valu
prepar
deriv
evalu
inhibit
activ
osteoclast
therefor
plane
prepar
deriv
evalu
biolog
activ
halomethyleniminium
salt
vm
reagent
found
extens
use
formyl
halogen
dehydroxyl
reagent
addit
mani
kind
heterocycl
compound
pyridin
quinolin
thienopyridin
quinolon
isoquinolon
naphthyridin
pyran
furan
effici
prepar
ring
closur
reaction
acylamid
vm
condit
although
n
acetamid
afford
oxazin
compound
reaction
vm
reagent
expect
reaction
b
furan
b
furan
prepar
b
furan
give
oxazin
compound
howev
reaction
vm
reagent
low
temperatur
afford
b
furo
pyridin
accompani
loss
cyanomethylcarbonyl
ethoxycarbonyl
group
respect
shown
scheme
reaction
vm
reagent
also
afford
b
furo
pyridin
result
similar
case
benzen
deriv
predict
benzo
b
furan
deriv
stabl
conjug
carbonyl
group
nitrogen
would
favor
cycliz
group
group
kind
b
furan
prepar
reaction
variou
acid
chlorid
e
chlorid
cinnamoyl
chlorid
e
e
chlorid
crotonyl
chlorid
chlorid
e
chlorid
physic
spectral
data
b
furan
list
tabl
see
supplementari
data
vm
reagent
prepar
pocl
dri
n
ndimethylformamid
dmf
ad
e
b
furan
reaction
mixtur
stir
h
orang
precipit
deposit
purif
orang
precipit
presum
immonium
salt
difficult
chemic
instabl
orang
suspens
precipit
water
treat
naoh
aqueou
solut
vigor
stir
orang
powder
obtain
method
orang
powder
could
also
obtain
treat
orang
suspens
triethylamin
method
b
recrystal
orang
powder
chcl
ethyl
acet
gave
orang
needl
repres
mp
method
b
scheme
h
nmr
hmbc
hmqc
ms
element
analysi
data
support
cycliz
oxazin
ring
fuse
benzo
b
furan
ring
compound
presum
novel
e
z
e
b
furo
acetaldehyd
characterist
exoformylmethylen
group
oxazin
ring
data
howev
insuffici
confirm
structur
attempt
prepar
singl
crystal
xray
analysi
unsuccess
thu
treat
diethyl
diethylamino
hornerwadsworthemmon
hwe
reaction
condit
afford
butadien
deriv
singl
crystal
success
prepar
xray
analysi
demonstr
z
fig
consequ
novel
oxazin
compound
determin
z
basi
physic
data
xray
analysi
reaction
vm
reagent
gave
mixtur
z
e
ratio
z
e
h
nmr
oxazin
ring
closur
mechan
reason
predomin
product
zisom
discuss
preliminari
commun
acetaldehyd
reaction
condit
zisom
preferenti
produc
reaction
five
predomin
zisom
z
isol
result
physic
data
list
tabl
see
supplementari
data
ring
closur
reaction
e
b
furan
vm
reagent
gener
two
differ
fusedr
oxazin
ring
pyridin
ring
depend
function
group
group
indispens
ring
closur
reaction
isomer
zisom
z
correspond
eisom
occur
solut
z
isom
z
dmsod
solut
isomer
e
timedepend
manner
reach
constant
ratio
z
e
h
accord
h
nmr
analysi
isomer
two
mixtur
z
e
b
z
e
also
examin
toluen
solut
found
reach
constant
equilibrium
ratio
z
e
h
hplc
analysi
fig
result
suggest
z
would
thermodynam
stabl
e
heat
format
z
calcul
kcalmol
lower
e
isomer
z
e
would
caus
formyl
group
conjug
exomethylen
support
absenc
isomer
z
z
z
prepar
nabh
reduct
respect
z
z
prepar
thirti
deriv
use
exoformylmethylen
group
method
c
nah
method
ticl
shown
scheme
compound
react
phosphon
reagent
presenc
nah
hwe
reaction
condi
pocl
dmf
select
hmbc
data
z
xray
analysi
structur
tion
afford
correspond
butadien
deriv
method
c
reaction
z
nsubstitut
dialkyl
gave
correspond
react
z
afford
correspond
z
reaction
z
diethyl
cyanomethylphosphon
tetraethyl
methylenediphosphon
gave
butadien
deriv
respect
noe
correl
h
h
c
observ
among
three
olefin
h
scheme
suggest
carboncarbon
doubl
bond
introduc
hwe
reaction
eform
two
carboncarbon
doubl
bond
butadien
moieti
orient
stran
conform
result
compat
structur
identifi
xray
analysi
fig
physic
spectral
data
butadien
deriv
list
tabl
see
supplementari
data
aldehyd
z
treat
afford
butadien
compound
respect
reaction
z
e
reaction
z
gave
respect
reaction
z
afford
unexpect
phosphon
appear
like
form
dehydr
instead
dephosphon
similar
knoevenagel
condens
mechan
termin
carboncarbon
doubl
bond
eform
observ
noe
h
hydrogen
phenyl
ring
scheme
expect
enhanc
bind
bone
hydroxyapatit
phosphon
group
introduc
molecul
aldehyd
z
react
presenc
titanium
tetrachlorid
ticl
nmethylmorpholin
method
produc
correspond
butadien
deriv
bear
phosphon
group
ratio
z
e
isomer
mixtur
comp
c
r
con
c
h
r
h
r
c
h
r
conch
ch
och
ch
r
h
r
c
h
r
conhc
h
ch
r
h
r
c
h
r
conh
ch
c
h
r
h
r
c
h
r
cooch
r
h
r
ch
r
cooc
h
r
h
r
c
h
r
cooc
ch
r
h
r
c
h
r
cn
r
h
r
c
h
r
p
oc
h
r
h
r
c
h
r
c
h
r
h
r
c
h
r
cooc
h
r
ch
r
c
h
r
br
r
h
r
c
h
r
con
c
h
r
h
r
br
r
h
r
c
h
r
conch
ch
och
ch
r
h
r
br
r
h
r
c
h
r
conhc
h
r
h
r
br
r
h
r
c
h
r
conh
ch
c
h
r
h
r
br
r
h
r
c
h
r
cooch
r
h
r
br
r
h
r
c
h
r
cooc
h
r
h
r
br
r
h
r
c
h
r
cooc
ch
r
h
r
br
r
h
r
c
h
r
cn
r
h
r
br
r
h
r
c
h
r
po
oc
h
r
h
r
br
r
h
r
c
h
r
po
oc
h
r
c
h
r
br
r
h
r
c
h
r
r
po
oc
h
conch
ch
och
ch
r
br
r
h
r
c
h
r
r
po
oc
h
cooc
h
r
br
r
h
r
c
h
r
r
p
oc
h
cn
r
br
r
h
r
c
h
r
r
po
oc
h
r
br
r
h
r
c
h
r
cooc
h
r
ch
r
h
r
och
r
c
h
r
conch
ch
och
ch
r
h
r
h
r
och
r
c
h
r
cooch
r
h
r
h
r
och
r
c
h
r
cooc
h
r
h
r
h
r
och
r
c
h
r
cooc
ch
r
h
r
h
r
och
r
c
h
r
cn
r
h
r
h
r
och
r
c
h
r
p
oc
h
r
h
r
h
r
och
r
c
h
r
cooc
h
r
ch
r
br
r
h
r
chcclc
h
r
cooc
h
r
h
r
br
r
h
r
chchc
h
r
po
oc
h
r
h
r
h
r
och
r
c
h
r
r
po
oc
h
conch
ch
och
ch
r
h
r
och
r
c
h
r
r
p
och
cooch
r
h
r
och
r
c
h
r
r
po
oc
h
cooc
h
b
r
h
r
och
r
c
h
r
r
po
oc
h
cn
c
r
h
r
och
r
c
h
r
r
po
oc
h
r
br
r
h
r
c
h
r
r
po
oc
h
termin
carbon
aldehyd
z
also
react
afford
butadien
deriv
respect
condit
method
tetraethyl
methylenediphosphon
produc
diphosphon
compound
slowli
reaction
respect
reaction
ethyl
diethylphosphonoacet
proceed
smoothli
give
monophosphon
respect
reaction
might
proceed
via
cyclic
titanium
complex
show
variou
kind
physiolog
activ
therefor
perform
two
kind
small
scale
bioactiv
assay
find
novel
bioactiv
compound
prepar
first
evalu
antiosteoclast
bone
resorpt
vitro
seven
repres
compound
z
z
prepar
work
cocultur
fresh
bone
marrow
preosteoclast
express
receptor
activ
nfjb
rank
calvari
osteoblast
express
ligand
rank
rankl
bone
resorb
osteoclast
develop
form
resorpt
pit
dentin
slice
pge
stimul
pit
format
estrogen
eg
estrogen
e
inhibit
pge
stimul
pit
format
suppress
rankl
effect
among
compound
test
ethyl
ester
phosphon
show
potent
inhibit
compar
e
wherea
amid
exoformylmethylen
compound
z
z
inact
fig
butadien
moieti
ester
phosphon
function
group
might
play
import
role
inhibit
osteoclast
sever
estrogen
agent
e
report
growth
inhibitori
activ
human
pancreat
carcinoma
mia
breast
cancer
therefor
aldehyd
butadien
deriv
select
repres
compound
evalu
growth
inhibitori
activ
vivo
mia
result
shown
tabl
butadien
amid
inhibit
mia
exoformylmethylen
compound
z
show
inhibitori
activ
butadien
ester
inact
type
cancer
cell
thu
two
seri
select
mia
inhibitori
new
compound
found
examin
inhibit
mechan
compound
prepar
conclus
establish
new
oxazin
ring
format
method
use
reaction
benzo
b
furan
vm
reagent
led
novel
applic
vilsmeier
reaction
heterocycl
e
z
acetaldehyd
bear
characterist
exoformylmethylen
group
prepar
reaction
unsatur
aldehyd
z
react
sever
phosphon
reagent
two
reaction
condit
afford
butadien
deriv
ester
phosphon
amid
group
termin
carbon
butadien
moieti
butadien
ester
phosphon
compound
show
potent
antiosteoclast
bone
resorpt
activ
compar
e
evalu
activ
prepar
compound
way
result
includ
detail
mechan
biolog
activ
report
elsewher
due
cours
exoformylmethylen
compound
z
butadien
amid
inhibit
cell
growth
mia
respect
vivo
studi
two
kind
biolog
activ
progress
aim
develop
new
drug
osteoporosi
pancreat
cancer
melt
point
determin
use
yanaco
microscop
hotstag
apparatu
uncorrect
h
nmr
c
nmr
hmbc
hmqc
spectra
obtain
jeol
jeol
jeol
spectromet
tetramethylsilan
intern
standard
ms
spectra
ms
hrm
obtain
use
jeol
eim
spectromet
element
analys
perform
chn
corder
yanaco
organ
extract
dri
anhydr
mgso
column
chromatographi
carri
wakogel
thin
layer
chromatographi
perform
e
merck
silica
gel
plate
mm
solut
g
mmol
dri
thf
ml
ad
chlorid
g
mmol
dri
thf
ml
mixtur
stir
h
solut
pour
water
brown
precipit
deposit
precipit
dissolv
chloroform
organ
layer
wash
satur
sodium
bicarbon
solut
brine
dri
solvent
evapor
give
residu
residu
wash
hexaneethyl
acet
recrystal
ethyl
acetatechloroform
afford
g
pale
brown
needl
data
express
mean
se
n
cont
control
e
signific
differ
p
versu
control
similar
reaction
describ
use
gave
g
mp
phosphoryl
chlorid
ml
mmol
ad
dri
dmf
ml
n
atmospher
stir
mixtur
ad
dropwis
solut
g
mmol
dri
dmf
ml
stir
h
addit
phosphoryl
chlorid
ml
mmol
ad
mixtur
stir
h
solut
pour
ice
water
extract
ethyl
acet
organ
layer
wash
brine
dri
solvent
evapor
residu
purifi
silica
gel
column
chromatographi
hexaneethyl
acet
recrystal
hexaneethyl
acet
give
acetaldehyd
z
gener
procedur
z
ez
mixtur
phosphoryl
chlorid
ml
mmol
dri
dmf
ml
stir
n
atmospher
min
mixtur
ad
dropwis
solut
g
mmol
dri
dmf
ml
stir
h
orang
precipit
deposit
mixtur
filtrat
precipit
treat
method
b
method
suspens
orang
precipit
water
ml
ad
dropwis
naoh
aqueou
solut
adjust
ph
mixtur
stir
min
obtain
orang
precipit
powder
method
b
suspens
orang
precipit
water
ml
ad
dropwis
solut
triethylamin
ml
mmol
chloroform
mixtur
vigor
stir
min
extract
chloroform
organ
chloroform
layer
wash
brine
dri
solvent
evapor
afford
orang
powder
recrystal
orang
powder
ethyl
acetatechloroform
gave
z
orang
needl
difficult
isol
pure
z
mixtur
ethyl
diethylphosphonoacet
ml
mmol
nah
oil
g
mmol
anhydr
thf
ml
stir
ad
dropwis
solut
z
g
mmol
anhydr
thf
ml
n
atmospher
mixtur
stir
h
mixtur
quench
h
concentr
reduc
pressur
residu
ad
satur
nh
cl
solut
extract
chloroform
organ
layer
wash
brine
dri
solvent
evapor
give
residu
recrystal
ethyl
acetatehexan
give
g
red
needl
physic
spectral
data
shown
supplementari
data
yellow
suspens
ticl
ml
mmol
carbon
tetrachlorid
ml
ad
dropwis
mixtur
z
g
mmol
g
mmol
anhydr
thf
ml
mixtur
stir
temperatur
h
nmethylmorpholin
ml
mmol
ad
solut
mixtur
stir
h
h
pour
water
chloroform
extract
wash
brine
dri
mgso
solvent
evapor
give
residu
purifi
silica
gel
column
chromatographi
chcl
ethyl
acet
recrystal
hexaneethyl
acet
give
g
red
needl
physic
spectral
data
shown
supplementari
data
solut
z
g
mmol
thf
ml
ad
sodium
borohydrid
g
mmol
mixtur
stir
min
mixtur
pour
water
concentr
evapor
reduc
pressur
give
precipit
precipit
filtrat
recrystal
thfchloroform
afford
calvari
osteoblast
precultur
preconflu
day
old
ddi
mice
shizuoka
laboratori
anim
center
hamamatsu
japan
fresh
bone
marrow
cell
weekold
ddi
male
mice
shizuoka
laboratori
anim
center
cocultur
amem
ph
sigma
chemic
co
st
loui
mo
usa
contain
fetal
calf
serum
fc
moreg
australia
new
zealand
nm
calcitriol
wako
pure
chemic
ind
osaka
japan
lm
prostaglandin
e
pge
sigma
chemic
co
day
mm
dish
greiner
tokyo
japan
precoat
collagen
cell
matrix
type
ia
nitta
gelatin
inc
osaka
japan
develop
osteoclast
cell
resuspend
collagenas
digest
plate
dentin
slice
mm
diamet
mm
height
amem
contain
nm
e
oxazin
deriv
plate
greiner
day
pit
format
slice
dip
n
naoh
treat
ultrason
wave
remov
cell
dri
stain
toluidin
blue
sodium
borat
pit
count
decreas
number
pit
slice
indic
antibon
resorpt
activ
test
compound
materi
method
measur
growth
inhibitori
activ
cancer
cell
line
reagent
dimethyl
sulfoxid
dmso
purchas
sigma
chemic
co
stock
solut
prepar
compound
prepar
dissolv
compound
dmso
lm
dilut
subsequ
prepar
growth
medium
dmem
emem
final
concentr
dmso
growth
medium
made
less
mia
human
pancreat
carcinoma
human
adenocarcinoma
breast
purchas
japan
health
scienc
foundat
grown
emem
mia
grown
dmem
medium
supplement
fetal
calf
serum
multis
tm
ml
antibioticantimycot
gibco
alamarblu
tm
biosourc
assay
use
measur
cell
cytotox
human
cell
seed
cell
growth
mediumwel
flat
bottom
tissu
cultur
plate
nunc
cell
incub
h
humidifi
atmospher
co
air
next
growth
media
plate
elimin
growth
medium
contain
drug
ad
triplic
well
cell
incub
continu
h
follow
incub
plate
alamarblu
tm
ad
well
plate
set
incub
addit
h
live
cell
count
micropl
reader
spectra
max
molecular
devic
use
excit
wavelength
nm
emiss
wavelength
nm
